Skip to content

Nutritional Status and Hidradenitis Suppurativa (Acne Inversa)

Role of Nutritionist in the Multidisciplinary Approach of Hidradenitis Suppurativa (Acne Inversa)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03683238
Acronym
NutriHidra
Enrollment
81
Registered
2018-09-25
Start date
2015-05-31
Completion date
2018-05-31
Last updated
2018-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Composition, Hidradenitis Suppurativa, Mediterranean Diet, Trimethylamine N-oxide (TMAO), Vitamin D Deficiency

Brief summary

Hidradenitis suppurativa (HS) is a chronic inflammatory, debilitating skin disorder. The exacerbating factors of HS include nutrition and adiposity. The objective of this study was to investigate the relationships between body composition and the adherence to the Mediterranean diet (MD) with the severity of HS in a sample of naïve-treatment patients with HS. In the wake of this evidence, in the study to investigate the relationships between nutritional status, the adherence to the MD, body composition, and the severity of HS in a sample of naïve-treatment patients with HS compared to control group matched for sex, age, and body weight.

Interventions

DIETARY_SUPPLEMENTMediterranean Diet

We aim to determine the effects of the traditional Mediterranean Diet on Hidradenitis suppurativa

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy subjects of both gender * treatment-naïve patients * had HS diagnosed ≥6 months before study initiation wash out therapy for at least 3 months

Exclusion criteria

* occasional or current of use of drugs for HS, including topical antibiotics and systemic treatments (such as clindamycin-rifampicin, tetracycline, Rifampicin-moxifloxacin-metronidazole, ertapenem, acitretin, cyclosporine A, dapsone, isotretinoin, biologics; * hypocaloric diet in the last three months or specific nutritional regimens; * vitamin/mineral or antioxidant supplementation; * occasional or current of use of drugs that could influence fluid balance, including non-steroidal anti-inflammatory drugs, hormone replacement therapy.

Design outcomes

Primary

MeasureTime frameDescription
Adherence to Mediterranean Diet by Predimed QuestionnaireApril 2015 to April 2018Validated 14-item tool of adherence to the Mediterranean diet, with three categories of adherence (≤5, low adherence, 6-9, average adherence and ≥10 points, high adherence)
Phase angleApril 2015 to April 2018Phase angle was performed using a BIA phase-sensitive system by experienced observers (an 800-µA current at a frequency single-frequency of 50 kHz BIA 101 RJL, Akern Bioresearch, Florence, Italy).
Trimethylamine N-oxide plasma levelsApril 2015 to April 2018ultra high-performance liquid chromatography

Secondary

MeasureTime frameDescription
Vitamin DApril 2015 to April 201825 OH vitamin D assay for the LIAISON automated analyzer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026